发明名称 Truncated platelet-activating factor acetylhydrolase
摘要 <p>A purified and isolated human plasma platelet-activating factor acetylhydrolase (PAF-AH) polypeptide fragment which is lacking up to the first twelve N-terminal amino acids of the mature human PAF-AH amino acid sequence set out in SEQ ID NO:8, his variant or variant fragment. An isolated polynucleotide encoding a human PAF-AH which is a DNA, a DNA vector comprising said DNA, a host cell stably transformed or transfected with DNA, a method of producing a PAF-AH comprising growing a host cell and a pharmaceutical composition comprising the PAF-AH. PAF-AH and said pharmaceutical composition are useful for the treatment of pleurisy, asthma, rhinitis, necrotizing enterocolitis, acute respiratory distress syndrome, acute pancreatitis, reperfusion injury, septicemia, preterm labor or neurological disease associated with HIV infection.</p>
申请公布号 SK286518(B6) 申请公布日期 2008.12.05
申请号 SK19990000473 申请日期 1997.08.13
申请人 ICOS CORPORATION 发明人 COUSENS LAWRENCE S.;EBERHARDT CHRISTINE D.;GRAY PATRICK;TRONG HAI LE;TJOELKER LARRY W.;WILDER CHERYL L.
分类号 C12N15/09;A61K38/00;A61K38/36;A61P11/06;A61P25/00;A61P27/16;C12N;C12N1/19;C12N1/21;C12N5/10;C12N9/12;C12N9/14;C12N9/18;C12R1/19;C12R1/91 主分类号 C12N15/09
代理机构 代理人
主权项
地址